Clinical Roundup Definitions of malnutrition apply differently depending on cancer type February 28, 2020Vol.46 No.09
In Brief Jennifer Cullen named associate director of Cancer Population Sciences at Case CCC February 28, 2020Vol.46 No.09
In Brief Aaron Gerds named medical director of Clinical Research Office at Case CCC February 28, 2020Vol.46 No.09
FDA approved 11 new agents, 30 supplemental indications in cancer in 2019 February 28, 2020Vol.46 No.09By Alexandria Carolan
ODAC: Thumbs up for Eli Lilly’s Cyramza, thumbs down for STEBA’s Tookad February 28, 2020Vol.46 No.09By Paul Goldberg
Funding Opportunities DOD Lung Cancer Research Program to announce funding opportunities for FY20 February 21, 2020Vol.46 No.08
Drugs & Targets FDA grants capmatinib priority review in NSCLC indication February 21, 2020Vol.46 No.08
Drugs & Targets FDA grants Breakthrough Therapy Designation for Astellas’ and Seattle Genetics’ agent Padcev in bladder cancer indication February 21, 2020Vol.46 No.08
Drugs & Targets FDA accepts Valoctocogene Roxaparvovec for Priority Review February 21, 2020Vol.46 No.08
